Advanced search    

Search: authors:"C. Cooper"

13 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Impact of clinical osteoarthritis of the hip, knee and hand on self-rated health in six European countries: the European Project on OSteoArthritis

. Dennison (Principal Investigator), C. Cooper, M.H. Edwards. Compliance with ethical standards Ethical approval All procedures performed in studies involving human participants were in accordance with the

A comprehensive fracture prevention strategy in older adults: the European Union Geriatric Medicine Society (EUGMS) statement

Prevention of fragility fractures in older people has become a public health priority, although the most appropriate and cost-effective strategy remains unclear. In the present statement, the Interest Group on Falls and Fracture Prevention of the European Union Geriatric Medicine Society, in collaboration with the International Association of Gerontology and Geriatrics for the ...

Erratum to: Management of osteoporosis of the oldest old

, London , UK 8 A. Diez-Perez Servicio de Medicina Interna y Enfermedades Infecciosas, Hospital del Mar-IMIM and RETICEF , Barcelona , Spain 9 C. Cooper NIHR Musculoskeletal Biomedical Research Unit

Fracture rate in patients with myasthenia gravis: the general practice research database

Summary The aim of this study was to evaluate fracture risk after onset of myasthenia gravis using the UK General Practice Research Database. Overall fracture risk is not statistically increased compared with age- and gender-matched controls irrespective of glucocorticoid use, but was increased in those using antidepressants, anxiolytics or anticonvulsants. Introduction Myasthenia ...

Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study

Summary Previous studies evaluated the association between proton pump inhibitor (PPI) use and subsequent fracture risk, but they showed ambiguous results. Therefore, the objective was to evaluate this association in a different study population. Our findings show that there is probably no causal relationship between PPI use and hip fracture risk. Introduction Previous studies ...

Erratum to: Impact of nutrition on muscle mass, strength, and performance in older adults

, Belgium 2 J.-P. Bonjour 3 N. Yoshimura Department of Joint Disease Research, 22nd Century Medical and Research Center, The University of Tokyo , Tokyo , Japan 4 C. Cooper NIHR Musculoskeletal Biomedical ... Research Unit, Institute of Musculoskeletal Sciences, University of Oxford , Oxford , UK 5 C. Cooper MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital , Southampton

Antipsychotic use and the risk of hip/femur fracture: a population-based case–control study

, Utrecht, The Netherlands 1 ) Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University , Utrecht, The Netherlands 2 C. Cooper Institute of

Use of β-Blockers and the Risk of Hip/Femur Fracture in the United Kingdom and The Netherlands

Data from in vivo studies have indicated a role for β-blockers in the prevention of bone loss. Some epidemiological studies have found protective effects of β-blockers on fracture risk. However, there is limited information on the association with cumulative dose and type of β-blockers used. We conducted two case-control studies using data from the UK General Practice Research ...

Validation of the IOF quality of life questionnaire for patients with wrist fracture

, University of Milan , Italy S. Boonen, University of Leuven , Belgium P.M. Christensen, University of Odense , Denmark C. Cooper, University of Southampton , UK J.P. Devogelaer, St. Luc University Hospital ... subjects. The data sets (baseline data, three questionnaires) were sent to C. Cooper (Southampton) for data analysis. The wrist fracture questionnaire was scored as follows: Every question had five answer

Use of anti-depressants and the risk of fracture of the hip or femur

Netherlands 2 A. C. G. Egberts Department of Clinical Pharmacy, University Medical Centre Utrecht , Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands 3 C. Cooper Institute of Musculoskeletal Sciences

Use of anti-depressants and the risk of fracture of the hip or femur

Netherlands 2 A. C. G. Egberts Department of Clinical Pharmacy, University Medical Centre Utrecht , Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands 3 C. Cooper Institute of Musculoskeletal Sciences

Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW)

Department of Medicine, Hospital del Mar-IMIM-Autonomous, University of Barcelona , Barcelona, Spain 8 C. Cooper Institute of Musculoskeletal Sciences, University of Oxford , Oxford, UK 9 C. Cooper MRC

The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design

8 P. Delmas Department of Rheumatology , Hpital Edouard Herriot, 5 Place d'Arsonval, Lyon, France 69437 9 C. Cooper Institute of Musculoskeletal Sciences, University of Oxford , Oxford, UK 10 J ... . Pfeilschifter Alfried Krupp Krankenhaus, Department of Internal Medicine III , Essen, Germany 11 C. Cooper MRC Epidemiology Resource Centre, University of Southampton, Southampton General Hospital , Southampton